Astatine-211 based radionuclide therapy: Current clinical trial landscape

Per Albertsson, Tom Bäck, Karin Bergmark, Andreas Hallqvist, Mia Johansson, Emma Aneheim, Sture Lindegren, Chiara Timperanza, Knut Smerud, Stig Palm

Open source

DOI: 10.3389/fmed.2022.1076210
Published: 2023-01-06
Container: Frontiers in Medicine
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fmed.2022.1076210,
  title = {Astatine-211 based radionuclide therapy: Current clinical trial landscape},
  author = {Per Albertsson and Tom Bäck and Karin Bergmark and Andreas Hallqvist and Mia Johansson and Emma Aneheim and Sture Lindegren and Chiara Timperanza and Knut Smerud and Stig Palm},
  year = {2023},
  journal = {Frontiers in Medicine},
  doi = {10.3389/fmed.2022.1076210},
  url = {https://doi.org/10.3389/fmed.2022.1076210}
}

RIS

TY  - JOUR
TI  - Astatine-211 based radionuclide therapy: Current clinical trial landscape
AU  - Per Albertsson
AU  - Tom Bäck
AU  - Karin Bergmark
AU  - Andreas Hallqvist
AU  - Mia Johansson
AU  - Emma Aneheim
AU  - Sture Lindegren
AU  - Chiara Timperanza
AU  - Knut Smerud
AU  - Stig Palm
PY  - 2023
JO  - Frontiers in Medicine
DO  - 10.3389/fmed.2022.1076210
UR  - https://doi.org/10.3389/fmed.2022.1076210
ER  -

APA

Albertsson, P., Bäck, T., Bergmark, K., Hallqvist, A., Johansson, M., Aneheim, E., Lindegren, S., Timperanza, C., Smerud, K., & Palm, S. (2023). Astatine-211 based radionuclide therapy: Current clinical trial landscape. Frontiers in Medicine. https://doi.org/10.3389/fmed.2022.1076210

Source records

crossref · retrieved 2026-09-27T03:43:56.779Z